Search

Author/Creator Topp, Andrew

2. Durability of sustained virological response to glecaprevir/pibrentasvir and resistance development: A long‐term follow‐up study. (14th March 2022)

Authors:
Poordad, Fred; Felizarta, Franco; Yao, Betty B.; Overcash, J. Scott; Hassanein, Tarek; Agarwal, Kosh; Gane, Edward; Shaw, David; Waters, Michael; Krishnan, Preethi; Topp, Andrew; Burroughs, Margaret; Nevens, Frederik
Journal:
Liver international
Issue:
Volume 42:Number 6(2022)
Page Start:
1278
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Children With Chronic HCV: Part 2 of the DORA Study. Issue 1 (23rd July 2021)

Authors:
Jonas, Maureen M.; Rhee, Susan; Kelly, Deirdre A.; Del Valle‐Segarra, Antonio; Feiterna‐Sperling, Cornelia; Gilmour, Susan; Gonzalez‐Peralta, Regino P.; Hierro, Loreto; Leung, Daniel H.; Ling, Simon C.; Lobzin, Yuri; Lobritto, Steven; Mizuochi, Tatsuki; Narkewicz, Michael R.; Sabharwal, Vishakha;...
Journal:
Hepatology
Issue:
Volume 74:Issue 1(2021)
Page Start:
19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗